The allure of achieving incredible gains in short time periods has many investors looking to strike it rich picking biotech stocks. But it's also attracted the attention of many fund companies, which are looking to capitalize on the average investor's interest in a more diversified form of biotech exposure. While my personal preference for the longer term investor looking to invest in biotech is to target a basket of stocks, in the following video, I detail one of the popular biotech ETF options that, in my opinion, investors should avoid.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Is This the Right Way to Play Biotech?
NASDAQ: IBB
iShares Trust - iShares Biotechnology ETF

This Biotech ETF isn't my best bet.
Brenton Flynn and The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend Gilead Sciences. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned






*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.